Book a demo

Cut patent&paper research from weeks to hours with PatSnap Eureka AI!

Try now
Cicas IP v. Meta Dynamic & Med-Surgical Services — CBYON System Patent Suit | PatSnap
Explore in Eureka
Case ID2:24-cv-00665
FiledAug 2024
ClosedJan 2025
Patent Litigation

Cicas IP v. Meta Dynamic & Med-Surgical Services: Dismissed Without Prejudice After 161 Days

Cicas IP, LLC asserted two CBYON System patents against medical technology defendants Meta Dynamic, Inc. and Med-Surgical Services, Inc. in the Eastern District of Texas. The parties jointly resolved the dispute and obtained a dismissal without prejudice — with a notable one-year tolling agreement preserving both sides’ claims — just 161 days after filing.

Resolution time
161days
161 days — faster than the median EDTX patent case, suggesting early resolution or settlement pressure
Patents asserted
2
US6511418B2 and US6850794B2 — CBYON System; surgical navigation and medical imaging technology
Outcome
Dismissed without Prejudice
Joint dismissal without prejudice; one-year tolling agreement preserves refiling rights from Aug 13, 2024
Cost ruling
Own Costs
Each party bears its own costs, expenses, and attorneys’ fees — no fee-shifting ordered
Published by PatSnap Insights Team · Verified by PatSnap Eureka Data
Case overview

CBYON System patent dispute ends in tolled dismissal without prejudice

On August 13, 2024, Cicas IP, LLC filed a patent infringement action in the Eastern District of Texas (Case No. 2:24-cv-00665) against Meta Dynamic, Inc. and Med-Surgical Services, Inc. The complaint asserted two patents — US6511418B2 and US6850794B2 — both relating to the CBYON System, a surgical navigation and medical imaging platform. Cicas IP, a dedicated IP licensing entity, targeted two defendants operating in the medical device and surgical services space.

The case closed on January 21, 2025, via a joint motion to dismiss filed by all parties. The court granted the motion and dismissed all claims and causes of action without prejudice. Critically, the dismissal order incorporates a one-year tolling agreement: any refiling within one year of the dismissal entry is deemed filed as of August 13, 2024, preserving the original filing date for statute of limitations and damages purposes. Each party was ordered to bear its own costs and attorneys’ fees.

At 161 days, the case resolved well within what typical Eastern District of Texas patent litigation timelines would suggest for a case reaching trial. The tolling agreement is commercially significant — it suggests the parties reached a business resolution but preserved optionality for either side to refile. The public record does not disclose whether a licensing agreement or financial settlement was reached, nor does it indicate which party initiated the joint motion. The without-prejudice posture means Cicas IP retains the right to reassert these patents within the tolling window.

Case at a glance
Case no.2:24-cv-00665
PlaintiffCicas IP, LLC
CourtTexas Eastern
JudgeN/A
FiledAugust 13, 2024
ClosedJanuary 21, 2025
Duration161 days
OutcomeDismissed without Prejudice
Verdict causeInfringement Action
BasisDismissed without Prejudice
Prior Art Intelligence
See what prior art exists on this patent.
Eureka scans millions of patents and papers to surface prior art that may have invalidated these claims before costly litigation begins.
Check Prior Art
Case data sourced from PACER / Texas Eastern District Court via PatSnap Eureka Litigation Intelligence Explore similar cases ↗
Case timeline

Filing to Dismissed without Prejudice in 161 days

161 days — faster than the median EDTX patent case, suggesting early resolution or settlement pressure

Case timeline: Complaint filed AUG 13 2024, NOV–DEC — 161 days total Horizontal timeline showing the three key events in Cicas IP, LLC v Meta Dynamic, Inc. from filing to resolution. Source: PACER, Texas Eastern District Court. AUG 13 2024 Complaint filed Pre-trial proceedings JAN 21 2025 Dismissed without Prejudice 161 DAYS TOTAL
Dismissal terms

Dismissed without prejudice: what the tolling agreement means for both parties

Legal mechanism

Without prejudice dismissal preserves the right to refile

A dismissal without prejudice does not adjudicate the merits of any claim. Unlike a with-prejudice dismissal, which extinguishes the asserted claims permanently, this order leaves Cicas IP free to reassert US6511418B2 and US6850794B2 against these defendants. The embedded tolling clause reinforces this: any refiling within one year is backdated to August 13, 2024, neutralising statute of limitations concerns that would otherwise accrue during the dismissed period.

No merits adjudication
Patent holder outcome

Cicas IP retains full enforcement rights under a one-year window

Cicas IP exits this action with its patents intact and unlitigated on the merits. The tolling agreement is particularly favourable: it prevents the defendants from later arguing that damages or claims are time-barred based on events occurring during the pendency of this case. If a licensing arrangement was reached privately, the without-prejudice structure also allows Cicas IP to refile if payment obligations are not met — a common IP licensing enforcement tactic.

Patents preserved; refiling right intact
Defendant outcome

Defendants face residual litigation risk through at least January 2026

For Meta Dynamic and Med-Surgical Services, the dismissal without prejudice provides no immunity from future suit. The tolling agreement cuts both ways: while it protects any counterclaims or defenses the defendants may have accrued, it equally preserves Cicas IP’s damages claims. Defendants cannot treat this as a final resolution unless a binding confidential agreement exists. The one-year refiling window — running to approximately January 2026 — means defendants should monitor the status of any licensing arrangement carefully.

No immunity; tolling window runs ~Jan 2026
Commercial implications

Tolling clauses in patent dismissals signal structured licensing negotiations

The inclusion of a mutual tolling agreement — covering both parties’ claims, counterclaims, and defenses — is consistent with a negotiated resolution still in progress, or a licensing deal with performance conditions. Medical device and surgical navigation companies operating in the CBYON System technology space should treat this case as a signal that these patents remain actively enforced. Other parties in the surgical navigation or image-guided surgery sector using related technology should assess their exposure before the refiling window closes.

Active enforcement signal for med-tech sector
Legal analysis based on PACER docket records for case 2:24-cv-00665 and PatSnap Eureka litigation intelligence Search PatSnap Eureka ↗
Parties and representation

Full party and counsel information

RoleNameTypeDetail
PlaintiffCicas IP, LLCCompanyIP licensing entity — holder of US6511418B2 and US6850794B2 (CBYON System patents)Search in Eureka ↗
DefendantMeta Dynamic, Inc.CompanyMeta Dynamic, Inc. and Med-Surgical Services, Inc. — medical device and surgical services companiesSearch in Eureka ↗
Co-DefendantMed-Surigcal Services, Inc.CompanySearch in Eureka ↗
Plaintiff counselChristopher A. HoneaAttorneyCounsel for Cicas IP, LLCSearch in Eureka ↗
Plaintiff law firmGarteiser Honea PLLCLaw FirmRepresenting Cicas IP, LLCSearch in Eureka ↗
Defendant counselJoshua M. MasurAttorneyCounsel for Meta Dynamic, Inc.Search in Eureka ↗
Defendant law firmHaley Guiliano, LLPLaw FirmRepresenting Meta Dynamic, Inc.Search in Eureka ↗
Presiding judgeJudge N/AJudgeTexas Eastern District CourtSearch in Eureka ↗
Official verdict

Official order — verbatim text

“Before the Court is the Joint Motion to Dismiss (the “Motion”) filed by CICAS IP LLC (“Plaintiff”) and Meta Dynamic, Inc. and Med-Surgical Services, Inc. (“Defendants”). (Dkt. No. 13.) In the Motion, the parties represent that the above-captioned case has been resolved and request dismissal of the above-captioned action WITHOUT prejudice. (Id. at 1.) The Parties agree and stipulate to the tolling of: Any time limitations or time bars related to any of their claims, counterclaims, or defenses, including but not limited to damages, such that any such action filed within one year after the entry of dismissal shall be deemed to have been filed on August 13, 2024 for purposes of any time limitation or time bar. Having considered the Motion, the Court finds that it should be and hereby is GRANTED. Accordingly, all claims and causes of action asserted between Plaintiff and Defendants in the above-captioned case are DISMISSED WITHOUT PREJUDICE. Each party is to bear its own costs, expenses, and attorneys’ fees. All pending requests for relief in the above-captioned case not explicitly granted herein are DENIED AS MOOT.”
Source: PACER Docket, Case 2:24-cv-00665, Texas Eastern District Court

The court’s order adopts the parties’ joint stipulation verbatim, granting the dismissal without prejudice and embedding the tolling agreement as an enforceable term of the order. The without-prejudice designation is legally significant: it means the court made no finding on infringement, validity, or claim construction. The tolling clause — deeming any refiling within one year as filed on August 13, 2024 — is an unusual provision that suggests the parties negotiated the order’s terms carefully, likely to preserve damages periods and avoid any accrual gap.

PACER case 2:24-cv-00665 · Public docket record Explore in Eureka ↗
Patent at issue

US6511418B2 & US6850794B2 — CBYON Surgical Navigation System Patents

Publication No.US6511418B2
Application No.US09/822545
Patent details
Productsurgical navigation and image-guided procedure system (CBYON System)
Cited in actionAugust 13, 2024

Publication No.US6850794B2
Application No.US09/957477
Patent details
Productsurgical navigation data processing and medical imaging methods (CBYON System)
Cited in actionAugust 13, 2024

US6511418B2 and US6850794B2 are both associated with the CBYON System — a surgical navigation platform designed to guide image-based medical procedures. These patents, filed under application numbers US09/822545 and US09/957477 respectively, sit within the technical domain of computer-assisted surgery, integrating real-time imaging data with navigational guidance to support precision interventions. The CBYON designation suggests a specific branded system covering both hardware and software components of intraoperative navigation.

For companies operating in surgical robotics, image-guided therapy, orthopedic navigation, or computer-assisted surgical planning, these patents represent a potential enforcement risk that this litigation has left unresolved on the merits. The fact that Cicas IP — a dedicated licensing entity — chose to assert both patents simultaneously against both a device distributor and a services provider suggests a broad enforcement theory covering the full commercial chain. Competitors and partners in this space should evaluate their product and service architectures against the claims of both patents before the tolling window expires.

Patent data sourced from USPTO via PatSnap Eureka patent database Search patent records in Eureka ↗
Freedom to operate

Should your team run an FTO against US6511418B2 and US6850794B2?

Any R&D team or product manager working on surgical navigation systems, image-guided procedures, or related computer-assisted surgery technology should treat this case as a trigger for a freedom-to-operate review. These patents remain valid, unexpired if still in force, and unlitigated on the merits. Cicas IP has demonstrated willingness to assert them in the Eastern District of Texas — a venue known for patent-holder-friendly outcomes — and the tolling agreement signals continued enforcement intent.

PatSnap Eureka’s FTO Search Agent can map the claim language of US6511418B2 and US6850794B2 against your product architecture, identify relevant prior art that could support invalidity arguments, and flag whether your technology falls within the likely claim scope. Given the without-prejudice dismissal and active tolling window, an FTO analysis completed now could inform both product design decisions and negotiation positioning if Cicas IP refiles or issues new demand letters.

PatSnap Eureka FTO Search

Run a freedom-to-operate analysis on US6511418B2 to assess your product’s exposure

Run FTO in Eureka →
Related litigation

Similar surgical navigation and medical device patent cases in EDTX

Explore comparable patent infringement actions in surgical navigation and computer-assisted surgery technology filed in the Eastern District of Texas, including cases involving IP licensing entities asserting medical device patents.

🔍
Access 40+ similar cases in PatSnap Eureka
Cicas IP, LLC patent enforcement history, Texas Eastern case history, Cicas IP, LLC’s full IP portfolio, and comparable case analysis
EDTX medical device dismissalsSurgical navigation patent casesCicas IP enforcement historyImage-guided surgery IP disputes
Unlock similar cases in Eureka →
Strategic implications

What this case signals for the surgical navigation IP landscape

A tolled dismissal without prejudice in the Eastern District of Texas rarely signals the end of enforcement — it typically signals a pause.

Tolling agreements signal conditional resolution, not finality

When a joint dismissal incorporates a one-year tolling clause, it suggests the parties reached an arrangement with performance conditions or are still negotiating final terms. IP professionals monitoring CBYON System-related patents should treat this as an open enforcement posture, not a resolved dispute. The patents remain unchallengeable on their merits based on this case record.

Eastern District of Texas remains a high-pressure venue for early resolution

At 161 days, this case resolved far faster than the typical EDTX patent case reaching claim construction. The venue’s reputation for plaintiff-friendly scheduling and rapid discovery timelines consistently incentivises defendants to negotiate early. Companies receiving demand letters tied to EDTX filings should factor in this settlement pressure dynamic when assessing litigation risk.

🔒
Full strategic analysis in PatSnap Eureka
Unlock deeper analysis of Cicas IP’s enforcement strategy in the medical device and surgical navigation sector, including EDTX district court risk patterns.
Prior art landscape analysisClaim scope risk mappingLicensing demand patterns
Unlock full analysis →
Analysis powered by PatSnap Eureka Litigation Intelligence Explore in Eureka ↗
Frequently asked questions

Cicas v Meta — key questions answered

Still have questions? PatSnap Eureka can answer them instantly from patent and litigation data. Ask Eureka ↗
PatSnap Eureka

Don’t wait for the refiling — assess your surgical navigation IP exposure now

With the CBYON System patents unlitigated on the merits and a one-year tolling window in effect, companies in surgical navigation and image-guided surgery face unresolved risk. PatSnap Eureka’s FTO and monitoring tools help you stay ahead of Cicas IP’s next move.

Ask anything about this case.
PatSnap Eureka searches patents and litigation data to answer instantly.
Powered by PatSnap Eureka
Link copied to clipboard

Related Litigation Cases

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.